EDGAR Filing Documents for 0001179110-06-015070

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001179110-06-015070

Filing Date

2006-07-12

Accepted

2006-07-12 17:57:37

Documents

Period of Report

2006-07-11

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 -	edgar.html	4
1	FORM 4 -	edgar.xml	4	3922
	Complete submission text file	0001179110-06-015070.txt		5868

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114

Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001

PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 300 ELLIOTT AVE WEST SUITE 500 SEATTLE WA 98119-4114

Business Address 206-286-2501

Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 06959253